Sodium Dichloroacetate

二氯乙酸钠

Report date: 2025/02/26 11:41:37
NME

Base Information

Drug NameSodium Dichloroacetate
Drug Alias NameSodium Dichloroacetate- DCACeresineCPC-211X-11SDCA +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate dehydrogenase complex stimulants
TargetsPyruvate dehydrogenase complex
Therapy Area/IndicationsHypoglycemiaDiabetes Mellitus, Type 1Diabetes Mellitus +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesSaol Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesYale UniversityUniversity Of FloridaSaol Therapeutics Inc
Inactive CompaniesCross Cancer InstituteEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentStanford University +[4] 
Active IndicationsHypoglycemiaDiabetes Mellitus, Type 1Pyruvate Dehydrogenase Complex Deficiency Disease +[4] 
Inactive IndicationsDiabetes MellitusAcidosis, LacticMELAS Syndrome +[5] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG